Literature DB >> 18405838

Whither antibacterial drug discovery?

Steven J Projan.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18405838     DOI: 10.1016/j.drudis.2008.03.010

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  16 in total

Review 1.  Bugs, drugs and chemical genomics.

Authors:  Terry Roemer; Julian Davies; Guri Giaever; Corey Nislow
Journal:  Nat Chem Biol       Date:  2011-12-15       Impact factor: 15.040

Review 2.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 3.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

4.  A MRSA-terious enemy among us: boosting MRSA vaccines.

Authors:  Scott D Kobayashi; Frank R DeLeo
Journal:  Nat Med       Date:  2011-02       Impact factor: 53.440

5.  General and condition-specific essential functions of Pseudomonas aeruginosa.

Authors:  Samuel A Lee; Larry A Gallagher; Metawee Thongdee; Benjamin J Staudinger; Soyeon Lippman; Pradeep K Singh; Colin Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

6.  Ranking essential bacterial processes by speed of mutant death.

Authors:  Larry A Gallagher; Jeannie Bailey; Colin Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-14       Impact factor: 11.205

7.  Systems-level antimicrobial drug and drug synergy discovery.

Authors:  Terry Roemer; Charles Boone
Journal:  Nat Chem Biol       Date:  2013-04       Impact factor: 15.040

Review 8.  Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics.

Authors:  Trevor L Kane; Katelyn E Carothers; Shaun W Lee
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

Review 9.  Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases.

Authors:  Meredith A Mintzer; Eric L Dane; George A O'Toole; Mark W Grinstaff
Journal:  Mol Pharm       Date:  2011-12-13       Impact factor: 4.939

10.  Characterization of bacteriophages virulent for Clostridium perfringens and identification of phage lytic enzymes as alternatives to antibiotics for potential control of the bacterium.

Authors:  Bruce S Seal
Journal:  Poult Sci       Date:  2013-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.